Nowadays which emergency contraception? Comparison between past and present: latest news in terms of clinical efficacy, side effects and contraindications

References

• Gemzell-Danielsson K, Meng CX. Emergency contraception: potential role of ulipristal acetate. Int J Womens Health 2010;2:53–61.
   PubMedGoogle Scholar
• Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, Sogor L, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010;375:555–562.
   PubMed Web of Science ®Google Scholar
• Marions L, Hultenby K, Lindell I, Sun X, Ståbi B, Gemzell Danielsson K. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol 2002;100:65–71.
   PubMed Web of Science ®Google Scholar
• Yuzpe AA, Lancee WJ. Ethinylestradiol and dl-norgestrel as a postcoital contraceptive. Fertil Steril 1977;28:932–936.
   PubMed Web of Science ®Google Scholar
• Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998;352:428–433.
   PubMed Web of Science ®Google Scholar
• von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G, Ng E, et al.; WHO Research Group on Post-ovulatory Methods of Fertility Regulation. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360:1803–1810.
   PubMed Web of Science ®Google Scholar
• Trussell J, Ellertson C, von Hertzen H, Bigrigg A, Webb A, Evans M, Ferden S, Leadbetter C. Estimating the effectiveness of emergency contraceptive pills. Contraception 2003;67:259–265.
   PubMed Web of Science ®Google Scholar
• Fine PM. Update on emergency contraception. Adv Ther 2011;28:87–90.
   PubMedGoogle Scholar
• Danielsson KG. Mechanism of action of emergency contraception. Contraception 2010;82:404–409.
   PubMedGoogle Scholar
• Novikova N, Weisberg E, Stanczyk FZ, Croxatto HB, Fraser IS. Effectiveness of levonorgestrel emergency contraception given before or after ovulation – a pilot study. Contraception 2007;75:112–118.
   PubMed Web of Science ®Google Scholar
• Wilcox AJ, Baird DD, Dunson DB, McConnaughey DR, Kesner JS, Weinberg CR. On the frequency of intercourse around ovulation: evidence for biological influences. Hum Reprod 2004;19: 1539–1543.
   PubMed Web of Science ®Google Scholar
• Danielsson KG, Swahn ML, Westlund P, Johannisson E, Seppälä M, Bygdeman M. Effect of low daily doses of mifepristone on ovarian function and endometrial development. Hum Reprod 1997;12:124–131.
   PubMed Web of Science ®Google Scholar
• Shoupe D, Mishell DR. Jr, Page MA, Madkour H, Spitz IM, Lobo RA. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase. Am J Obstet Gynecol 1987;157:1421–1426.
   PubMed Web of Science ®Google Scholar
• van der Stege JG, Pahl-van Beest EH, Beerthuizen RJ, van Lunsen RH, Scholten PC, Bogchelman DH. Effects of a preovulatory single low dose of mifepristone on ovarian function. Eur J Contracept Reprod Health Care 2006;11:104–108.
   PubMed Web of Science ®Google Scholar
• Lalitkumar PG, Sengupta J, Ghosh D. Endometrial tumor necrosis factor alpha (TNFalpha) is a likely mediator of early luteal phase mifepristone-mediated negative effector action on the preimplantation embryo. Reproduction 2005;129:323–335.
   PubMedGoogle Scholar
• Lalitkumar PG, Lalitkumar S, Meng CX, Stavreus-Evers A, Hambiliki F, Bentin-Ley U, Gemzell-Danielsson K. Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model. Hum Reprod 2007;22:3031–3037.
   PubMed Web of Science ®Google Scholar
• International Consortium for Emergency Contraception (ICEC), International Federation of Gynecology & Obstetrics (FIGO). Statement on mechanism of action (October 2008). http://www.figo.org/news/joint-statement-internationalconsortium-emergency-contraception.
   Google Scholar
• Mozzanega B, Cosmi E. How do levonorgestrel-only emergency contraceptive pills prevent pregnancy? Some considerations. Gynecol Endocrinol 2011;27:439–442.
   PubMed Web of Science ®Google Scholar
• Okewole IA, Arowojolu AO, Odusoga OL, Oloyede OA, Adeleye OA, Salu J, Dada OA. Effect of single administration of levonorgestrel on the menstrual cycle. Contraception 2007;75:372–377.
   PubMed Web of Science ®Google Scholar
• Durand M, Seppala M, Cravioto Mdel C, Koistinen H, Koistinen R, González-Macedo J, Larrea F. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle. Contraception 2005;71:451–457.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen J, Wang Y, Ren F, Yu W, Cheng L. Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod 2009;24:1605–1611.
   PubMed Web of Science ®Google Scholar
• Kim A, Bridgeman MB. Ulipristal Acetate (ella): A Selective Progesterone Receptor Modulator For Emergency Contraception. P T 2011;36:325–331.
   PubMedGoogle Scholar
• Blithe DL, Nieman LK, Blye RP, Stratton P, Passaro M. Development of the selective progesterone receptor modulator CDB-2914 for clinical indications. Steroids 2003;68:1013–1017.
   PubMed Web of Science ®Google Scholar
• Stratton P, Hartog B, Hajizadeh N, Piquion J, Sutherland D, Merino M, Lee YJ, Nieman LK. A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women. Hum Reprod 2000;15:1092–1099.
   PubMed Web of Science ®Google Scholar
• Croxatto HB, et al. The effects of immediate pre-ovulatory administration of 30 mg ulipristal acetate on follicular rupture. in 8th Congress of the European Society of Gynecology. Sep 10–13, 2009; Rome, Italy.
   Google Scholar
• McKeage K, Croxtall JD. Ulipristal acetate: a review of its use in emergency contraception. Drugs 2011;71:935–945.
   PubMed Web of Science ®Google Scholar
• Keenan JA. Ulipristal acetate: contraceptive or contragestive? Ann Pharmacother 2011;45:813–815.
   PubMed Web of Science ®Google Scholar
• Stirling A, Glasier A. Estimating the efficacy of emergency contraception–how reliable are the data? Contraception 2002;66:19–22.
   PubMed Web of Science ®Google Scholar
• Cheng L, Gülmezoglu AM, Piaggio G, Ezcurra E, Van Look PF. Interventions for emergency contraception. Cochrane Database Syst Rev 2008;CD001324.
   PubMed Web of Science ®Google Scholar
• Creinin MD, Schlaff W, Archer DF, Wan L, Frezieres R, Thomas M, Rosenberg M, Higgins J. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006;108:1089–1097.
   PubMed Web of Science ®Google Scholar
• Fine P, Mathé H, Ginde S, Cullins V, Morfesis J, Gainer E. Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstet Gynecol 2010;115:257–263.
   PubMed Web of Science ®Google Scholar
• Gainer E, Massai R, Lillo S, Reyes V, Forcelledo ML, Caviedes R, Villarroel C, Bouyer J. Levonorgestrel pharmacokinetics in plasma and milk of lactating women who take 1.5 mg for emergency contraception. Hum Reprod 2007;22:1578–1584.
   PubMed Web of Science ®Google Scholar